Altria’s chairman, CEO and president, and its CFO will discuss the company’s third-quarter results during a webcast on October 26. Read More
Tags :United States
There is a widely-held view that tobacco companies will bear the costs of publishing so-called ‘corrective’ statements, whereas it is surely the smokers who will pay.Read More
A prohibition on the distribution of free samples of tobacco products is said to be among the US FDA’s most important provisions in helping to reduce youth access to such products.Read More
New research has found that a strategy of replacing cigarette smoking with vaping would yield substantial life year gains in the US, even given pessimistic assumptions.Read More
The huge delay in implementing court-ordered, public ‘corrective statements’ by US tobacco manufacturers could render them counterproductive in the reduced-risk age.Read More
It is often said that there is nothing more important than the welfare of children, but clearly money is seen by many as being an exception to that rule.Read More
Up to 210 healthy adults are needed for a study due to be conducted in the US into the uptake of nicotine through the use of vaping and smoking devices and products.Read More
The US Food and Drug Administration has been carrying out 'cruel and unnecessary’ research on ‘the effects of nicotine on squirrel monkeys’, even though monkeys don’t smoke or vape.Read More
22nd Century says that being free of a 'restrictive license agreement' with British American Tobacco means that it can pursue more lucrative strategic partnerships.Read More
Tobacco accounted for a third of the value of the organic commodities produced last year in the US state of Virginia.Read More